Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 36% ± 12% | |
lung | 16 studies | 42% ± 17% | |
intestine | 12 studies | 38% ± 18% | |
eye | 10 studies | 31% ± 15% | |
brain | 10 studies | 31% ± 10% | |
kidney | 9 studies | 45% ± 9% | |
liver | 6 studies | 35% ± 20% | |
bone marrow | 5 studies | 29% ± 8% | |
pancreas | 4 studies | 46% ± 19% | |
placenta | 4 studies | 51% ± 23% | |
heart | 4 studies | 26% ± 8% | |
uterus | 4 studies | 49% ± 16% | |
lymph node | 4 studies | 45% ± 14% | |
breast | 4 studies | 33% ± 5% | |
adrenal gland | 3 studies | 39% ± 3% | |
prostate | 3 studies | 23% ± 5% | |
skin | 3 studies | 27% ± 10% | |
thymus | 3 studies | 62% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7379.34 | 1445 / 1445 | 100% | 239.62 | 183 / 183 |
kidney | 100% | 11336.25 | 89 / 89 | 100% | 250.03 | 901 / 901 |
ovary | 100% | 4598.83 | 180 / 180 | 100% | 365.23 | 430 / 430 |
pancreas | 100% | 5178.55 | 328 / 328 | 100% | 219.41 | 178 / 178 |
stomach | 100% | 7447.86 | 359 / 359 | 100% | 271.78 | 286 / 286 |
uterus | 100% | 5125.99 | 170 / 170 | 100% | 247.85 | 459 / 459 |
skin | 100% | 6739.37 | 1808 / 1809 | 100% | 220.53 | 472 / 472 |
thymus | 100% | 6110.96 | 653 / 653 | 100% | 235.97 | 604 / 605 |
breast | 100% | 5956.14 | 459 / 459 | 100% | 277.50 | 1116 / 1118 |
intestine | 100% | 9019.16 | 966 / 966 | 100% | 290.04 | 526 / 527 |
bladder | 100% | 6285.43 | 21 / 21 | 100% | 292.57 | 502 / 504 |
adrenal gland | 100% | 16475.74 | 258 / 258 | 100% | 266.71 | 229 / 230 |
liver | 100% | 6441.25 | 225 / 226 | 100% | 278.59 | 406 / 406 |
prostate | 100% | 4810.21 | 244 / 245 | 100% | 204.56 | 501 / 502 |
lung | 99% | 5033.10 | 574 / 578 | 100% | 209.83 | 1155 / 1155 |
brain | 99% | 5841.33 | 2621 / 2642 | 100% | 191.59 | 705 / 705 |
adipose | 100% | 6178.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 237.13 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 233.09 | 29 / 29 |
muscle | 100% | 13325.88 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5042.23 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 221.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 98.11 | 1 / 1 |
blood vessel | 100% | 5826.31 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 18506.60 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 4210.37 | 695 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
GO_0006754 | Biological process | ATP biosynthetic process |
GO_0006119 | Biological process | oxidative phosphorylation |
GO_0042776 | Biological process | proton motive force-driven mitochondrial ATP synthesis |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0000275 | Cellular component | mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) |
GO_0005753 | Cellular component | mitochondrial proton-transporting ATP synthase complex |
GO_0005739 | Cellular component | mitochondrion |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0016020 | Cellular component | membrane |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0046933 | Molecular function | proton-transporting ATP synthase activity, rotational mechanism |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | ATP5F1C |
Protein name | ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit) |
Synonyms | ATP5CL1 ATP5C1 ATP5C |
Description | FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(1) domain and the central stalk which is part of the complex rotary element. The gamma subunit protrudes into the catalytic domain formed of alpha(3)beta(3). Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits. . |
Accessions | ENST00000335698.4 [P36542-2] ENST00000356708.12 [P36542-1] P36542 |